美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Brookfield Real Assets Income Fund Inc.

13.11

+0.01000.08%

盤後：13.08-0.0300-0.23%16:08 EDT

成交量：18.14萬

成交額：237.79萬

市值：7.25億

市盈率：-8.10

高：13.13

開：13.12

低：13.09

收：13.10

資料載入中...

總覽公司新聞公告

Igm Biosciences, Inc.盤中異動急速下挫5.09%

Igm Biosciences, Inc.盤中異動急速拉昇5.10%報1.55美元

Igm Biosciences, Inc.盤中異動早盤股價大跌6.33%

Igm Biosciences, Inc.盤中異動急速下挫5.12%

Anaptysbio, Inc.盤中異動股價大漲5.01%報18.34美元

Anaptysbio, Inc.盤中異動急速拉昇5.04%報17.70美元

開發減肥療法公司Metsera(MTSR.US)IPO定價15-17美元/股籌資2.75億美元

Anaptysbio, Inc.盤中異動大幅上漲5.41%

Igm Biosciences, Inc.盤中異動早盤股價大漲5.85%

Igm Biosciences, Inc.盤中異動下午盤急速跳水5.37%

Anaptysbio, Inc.盤中異動股價大漲5.24%報16.68美元

Anaptysbio, Inc.盤中異動快速上漲5.52%報15.86美元

Igm Biosciences, Inc.盤中異動股價大跌6.14%報1.61美元

Igm Biosciences, Inc.盤中異動大幅下跌5.32%

Anaptysbio, Inc.盤中異動早盤大幅上漲5.68%報15.45美元

Igm Biosciences, Inc.盤中異動早盤股價大跌5.18%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/RA/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RA\",,,,,undefined,":{"symbol":"RA","market":"US","secType":"STK","nameCN":"Brookfield Real Assets Income Fund Inc.","latestPrice":13.11,"timestamp":1742414400000,"preClose":13.1,"halted":0,"volume":181439,"hourTrading":{"tag":"盘后","latestPrice":13.08,"preClose":13.11,"latestTime":"16:08 EDT","volume":116,"amount":1519.919928,"timestamp":1742414929379},"delay":0,"changeRate":0.000763,"change":0.01,"floatShares":55280700,"shares":55280700,"eps":-1.61933,"lyrEps":0,"amount":2377946.99126,"amplitude":0.003061,"volumeRatio":0.79535,"dividePrice":1.416,"prevYearClose":13.32,"fiveDayClose":13.26,"twentyDayClose":13.44},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RA\",,,,,undefined,":{"symbol":"RA","floatShares":55280700,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.79535,"shares":55280700,"dividePrice":1.416,"high":13.1301,"amplitude":0.003061,"preClose":13.1,"low":13.09,"week52Low":12.165,"pbRate":"--","week52High":13.77,"institutionHeld":0,"latestPrice":13.11,"eps":-1.61933,"divideRate":0.108009,"volume":181439,"delay":0,"ttmEps":-1.61933,"open":13.12,"prevYearClose":13.32,"prevWeekClose":13.11,"prevMonthClose":13.35,"prevQuarterClose":13.32,"fiveDayClose":13.26,"twentyDayClose":13.44,"sixtyDayClose":13.15},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RA\",params:#limit:5,,,undefined,":[{"date":"2025-03-13","symbol":"RA","amount":0.118,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-13","defaultRemindTime":1741872600000,"name":"Brookfield Real Assets Income Fund Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-27","payableDate":"2025-03-13","currency":"USD","dateTimestamp":1741838400000,"payDate":"2025-03-27"},{"date":"2025-02-06","symbol":"RA","amount":0.118,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-06","defaultRemindTime":1738852200000,"name":"Brookfield Real Assets Income Fund Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-02-20","payableDate":"2025-02-06","currency":"USD","dateTimestamp":1738818000000,"payDate":"2025-02-20"},{"date":"2025-01-10","symbol":"RA","amount":0.118,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-01-09","defaultRemindTime":1736519400000,"name":"Brookfield Real Assets Income Fund Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-01-23","payableDate":"2025-01-09","currency":"USD","dateTimestamp":1736485200000,"payDate":"2025-01-23"},{"date":"2025-01-09","symbol":"RA","amount":0.118,"announcedDate":"2024-12-27","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-01-09","defaultRemindTime":1736433000000,"name":"Brookfield Real Assets Income Fund Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-01-23","payableDate":"2025-01-09","currency":"USD","dateTimestamp":1736398800000,"payDate":"2025-01-23"},{"date":"2024-12-10","symbol":"RA","amount":0.118,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-10","defaultRemindTime":1733841000000,"name":"Brookfield Real Assets Income Fund Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-10","currency":"USD","dateTimestamp":1733806800000,"payDate":"2024-12-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RA\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-13","recordDate":"2016-12-15","paymentDate":"2016-12-22","value":0.199,"currency":"USD"},{"executeDate":"2017-03-14","recordDate":"2017-03-16","paymentDate":"2017-03-23","value":0.199,"currency":"USD"},{"executeDate":"2017-04-18","recordDate":"2017-04-20","paymentDate":"2017-04-27","value":0.199,"currency":"USD"},{"executeDate":"2017-05-16","recordDate":"2017-05-18","paymentDate":"2017-05-25","value":0.199,"currency":"USD"},{"executeDate":"2017-06-13","recordDate":"2017-06-15","paymentDate":"2017-06-22","value":0.199,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RA\",pageSize:16,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2508414914","title":"Igm Biosciences, Inc.盤中異動 急速下挫5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508414914","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508414914?lang=zh_tw&edition=fundamental","pubTime":"2025-02-03 22:31","pubTimestamp":1738593111,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时31分，Igm Biosciences, Inc.股票出现波动，股价快速下挫5.09%。Igm Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Briacell Therapeutics Corp.涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为313.16%、207.52%、126.35%，振幅较大的相关个股有Briacell Therapeutics Corp.、Tc Biopharm  Plc、Hcw Biologics Inc.，振幅分别为11.95%、11.75%、10.78%。Igm Biosciences, Inc.公司简介：IGM Biosciences Inc是一家从事 IgM 抗体疗法开发的生物技术公司，用于治疗癌症、传染病以及自身免疫和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502032231519616fb54&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502032231519616fb54&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","RA","BK4139","SLE","BK4077","IGMS"],"gpt_icon":0},{"id":"2507624901","title":"Igm Biosciences, Inc.盤中異動 急速拉昇5.10%報1.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507624901","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507624901?lang=zh_tw&edition=fundamental","pubTime":"2025-01-30 22:54","pubTimestamp":1738248864,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日22时54分，Igm Biosciences, Inc.股票出现波动，股价急速上涨5.10%。Igm Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.41%。其相关个股中，Tectonic Therapeutic, Inc.、Alterity Therapeutics Limited、Kazia Therapeutics Limited涨幅较大，Kazia Therapeutics Limited、Alterity Therapeutics Limited、Silexion Therapeutics Corp较为活跃，换手率分别为1214.28%、157.83%、137.67%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Kazia Therapeutics Limited、Alterity Therapeutics Limited，振幅分别为56.41%、41.30%、36.77%。Igm Biosciences, Inc.公司简介：IGM Biosciences Inc是一家从事 IgM 抗体疗法开发的生物技术公司，用于治疗癌症、传染病以及自身免疫和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130225424a2345939&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130225424a2345939&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","RA","BK4139","BK4077","SLE","IGMS"],"gpt_icon":0},{"id":"2507631625","title":"Igm Biosciences, Inc.盤中異動 早盤股價大跌6.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507631625","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507631625?lang=zh_tw&edition=fundamental","pubTime":"2025-01-29 22:38","pubTimestamp":1738161510,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日22时38分，Igm Biosciences, Inc.股票出现异动，股价急速跳水6.33%。Igm Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Igm Biosciences, Inc.公司简介：IGM Biosciences Inc是一家从事 IgM 抗体疗法开发的生物技术公司，用于治疗癌症、传染病以及自身免疫和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129223830961396a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129223830961396a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RA","BK4139","BK4077","OCEA","SLE","IGMS","BK4505"],"gpt_icon":0},{"id":"2507528655","title":"Igm Biosciences, Inc.盤中異動 急速下挫5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507528655","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507528655?lang=zh_tw&edition=fundamental","pubTime":"2025-01-29 03:55","pubTimestamp":1738094125,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日03时55分，Igm Biosciences, Inc.股票出现波动，股价快速跳水5.12%。Igm Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。Igm Biosciences, Inc.公司简介：IGM Biosciences Inc是一家从事 IgM 抗体疗法开发的生物技术公司，用于治疗癌症、传染病以及自身免疫和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012903552598758db1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012903552598758db1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4077","RA","IGMS","BK4505","SLE","BK4139"],"gpt_icon":0},{"id":"2507330544","title":"Anaptysbio, Inc.盤中異動 股價大漲5.01%報18.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507330544","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507330544?lang=zh_tw&edition=fundamental","pubTime":"2025-01-29 02:16","pubTimestamp":1738088199,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日02时16分，Anaptysbio, Inc.股票出现波动，股价急速拉升5.01%。截至发稿，该股报18.34美元/股，成交量12.134万股，换手率0.40%，振幅8.28%。Anaptysbio, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129021639abbb927c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129021639abbb927c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANAB","RA"],"gpt_icon":0},{"id":"2506589300","title":"Anaptysbio, Inc.盤中異動 急速拉昇5.04%報17.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506589300","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506589300?lang=zh_tw&edition=fundamental","pubTime":"2025-01-28 01:10","pubTimestamp":1737997837,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日01时10分，Anaptysbio, Inc.股票出现波动，股价急速拉升5.04%。截至发稿，该股报17.70美元/股，成交量20.4523万股，换手率0.67%，振幅6.23%。Anaptysbio, Inc.股票所在的生物技术行业中，整体涨幅为0.83%。其相关个股中，Akero Therapeutics, Inc.、Dogwood Therapeutics, Inc.、89Bio, Inc.涨幅较大，Onconetix, Inc.、Dogwood Therapeutics, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为2096.39%、654.04%、239.44%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Onconetix, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为103.25%、85.35%、65.16%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501280110379874c896&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501280110379874c896&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RA","ANAB"],"gpt_icon":0},{"id":"2506430141","title":"開發減肥療法公司Metsera(MTSR.US)IPO定價15-17美元/股 籌資2.75億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506430141","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506430141?lang=zh_tw&edition=fundamental","pubTime":"2025-01-27 23:45","pubTimestamp":1737992709,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，专注于肥胖治疗的生物技术公司Metsera周一公布了其首次公开募股的相关条款。按照价格区间中值计算，Metsera的全面摊薄市值将达到18亿美元。目前，MET-097i正在进行一项IIb期临床试验，评估其在无2型糖尿病的肥胖或超重患者中的安全性和疗效。此外，Metsera还计划开展一项针对伴有2型糖尿病的肥胖或超重患者的独立IIb期研究。预计定价将在2025年1月27日这一周内完成。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1244825.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["RA","IPO"],"gpt_icon":0},{"id":"2505040335","title":"Anaptysbio, Inc.盤中異動 大幅上漲5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505040335","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505040335?lang=zh_tw&edition=fundamental","pubTime":"2025-01-24 03:08","pubTimestamp":1737659326,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日03时08分，Anaptysbio, Inc.股票出现异动，股价大幅拉升5.41%。截至发稿，该股报17.06美元/股，成交量52.4158万股，换手率1.72%，振幅9.27%。Anaptysbio, Inc.股票所在的生物技术行业中，整体涨幅为1.12%。其相关个股中，Dogwood Therapeutics, Inc.、Nutriband Inc C/Wts 、Hepion Pharmaceuticals, Inc.涨幅较大，Dogwood Therapeutics, Inc.、Hepion Pharmaceuticals, Inc.、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为6572.49%、4207.87%、700.58%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Nutriband Inc C/Wts 、Revolution Medicines Inc C/Wts 17/12/2026 ，振幅分别为948.57%、145.99%、84.55%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124030846a22d3fe4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124030846a22d3fe4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANAB","BK4139","RA"],"gpt_icon":0},{"id":"2505724155","title":"Igm Biosciences, Inc.盤中異動 早盤股價大漲5.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505724155","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505724155?lang=zh_tw&edition=fundamental","pubTime":"2025-01-22 22:35","pubTimestamp":1737556506,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日22时35分，Igm Biosciences, Inc.股票出现异动，股价急速拉升5.85%。Igm Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。其相关个股中，Immunoprecise Antibodies Ltd.、Nutriband Inc C/Wts 、Nutriband Inc.涨幅较大，Immunoprecise Antibodies Ltd.、Hepion Pharmaceuticals, Inc.、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为476.52%、103.15%、55.01%，振幅较大的相关个股有Immunoprecise Antibodies Ltd.、Nutriband Inc C/Wts 、Metagenomi, Inc.，振幅分别为27.53%、23.26%、17.28%。Igm Biosciences, Inc.公司简介：IGM Biosciences Inc是一家从事 IgM 抗体疗法开发的生物技术公司，用于治疗癌症、传染病以及自身免疫和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122223506960cffc7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122223506960cffc7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","IGMS","BK4077","RA","SLE"],"gpt_icon":0},{"id":"2505178344","title":"Igm Biosciences, Inc.盤中異動 下午盤急速跳水5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505178344","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505178344?lang=zh_tw&edition=fundamental","pubTime":"2025-01-22 03:19","pubTimestamp":1737487151,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日03时19分，Igm Biosciences, Inc.股票出现异动，股价大幅跳水5.37%。Igm Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.86%。其相关个股中，Dogwood Therapeutics, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Camp4 Therapeutics Corporation涨幅较大，Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Dermata Therapeutics, Inc.较为活跃，换手率分别为825.01%、521.93%、189.54%，振幅较大的相关个股有Channel Therapeutics Corporation、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Camp4 Therapeutics Corporation，振幅分别为96.32%、50.37%、46.97%。Igm Biosciences, Inc.公司简介：IGM Biosciences Inc是一家从事 IgM 抗体疗法开发的生物技术公司，用于治疗癌症、传染病以及自身免疫和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122031911abb383bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122031911abb383bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLE","RA","BK4139","BK4505","BK4077","IGMS"],"gpt_icon":0},{"id":"2505420457","title":"Anaptysbio, Inc.盤中異動 股價大漲5.24%報16.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505420457","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505420457?lang=zh_tw&edition=fundamental","pubTime":"2025-01-22 01:29","pubTimestamp":1737480548,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日01时29分，Anaptysbio, Inc.股票出现波动，股价快速上涨5.24%。截至发稿，该股报16.68美元/股，成交量20.6943万股，换手率0.68%，振幅5.62%。Anaptysbio, Inc.股票所在的生物技术行业中，整体涨幅为1.96%。其相关个股中，Dogwood Therapeutics, Inc.、Camp4 Therapeutics Corporation、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Dermata Therapeutics, Inc.较为活跃，换手率分别为781.68%、505.74%、187.36%，振幅较大的相关个股有Channel Therapeutics Corporation、Klotho Neurosciences Inc C/Wts 21/06/2029 、Dogwood Therapeutics, Inc.，振幅分别为96.32%、41.33%、38.48%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122012909986e5218&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122012909986e5218&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RA","BK4139","ANAB"],"gpt_icon":0},{"id":"2504945311","title":"Anaptysbio, Inc.盤中異動 快速上漲5.52%報15.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504945311","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504945311?lang=zh_tw&edition=fundamental","pubTime":"2025-01-18 01:22","pubTimestamp":1737134546,"startTime":"0","endTime":"0","summary":"北京时间2025年01月18日01时22分，Anaptysbio, Inc.股票出现波动，股价快速上涨5.52%。截至发稿，该股报15.86美元/股，成交量11.6732万股，换手率0.38%，振幅4.26%。Anaptysbio, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118012226abaed723&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118012226abaed723&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RA","ANAB","BK4139"],"gpt_icon":0},{"id":"2503403946","title":"Igm Biosciences, Inc.盤中異動 股價大跌6.14%報1.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503403946","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503403946?lang=zh_tw&edition=fundamental","pubTime":"2025-01-15 22:42","pubTimestamp":1736952147,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时42分，Igm Biosciences, Inc.股票出现波动，股价大幅下挫6.14%。Igm Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.05%。Igm Biosciences, Inc.公司简介：IGM Biosciences Inc是一家从事 IgM 抗体疗法开发的生物技术公司，用于治疗癌症、传染病以及自身免疫和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152242279604b755&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152242279604b755&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLE","BK4505","IGMS","RA","BK4077","BK4139"],"gpt_icon":0},{"id":"2503501493","title":"Igm Biosciences, Inc.盤中異動 大幅下跌5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503501493","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503501493?lang=zh_tw&edition=fundamental","pubTime":"2025-01-15 01:15","pubTimestamp":1736874944,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日01时15分，Igm Biosciences, Inc.股票出现波动，股价大幅下跌5.32%。Igm Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.60%。其相关个股中，Eterna Therapeutics Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Matinas Biopharma Holdings, Inc.涨幅较大，Eterna Therapeutics Inc.、Phio Pharmaceuticals Corp.、Soligenix, Inc.较为活跃，换手率分别为959.55%、516.25%、413.47%，振幅较大的相关个股有Eterna Therapeutics Inc.、Matinas Biopharma Holdings, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 ，振幅分别为170.74%、69.81%、69.33%。Igm Biosciences, Inc.公司简介：IGM Biosciences Inc是一家从事 IgM 抗体疗法开发的生物技术公司，用于治疗癌症、传染病以及自身免疫和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011501154596039b40&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011501154596039b40&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLE","BK4505","IGMS","RA","BK4077","BK4139"],"gpt_icon":0},{"id":"2503574016","title":"Anaptysbio, Inc.盤中異動 早盤大幅上漲5.68%報15.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503574016","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503574016?lang=zh_tw&edition=fundamental","pubTime":"2025-01-14 22:36","pubTimestamp":1736865404,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日22时36分，Anaptysbio, Inc.股票出现异动，股价快速上涨5.68%。截至发稿，该股报15.45美元/股，成交量6.5008万股，换手率0.21%，振幅5.92%。Anaptysbio, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。其相关个股中，Eterna Therapeutics Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Seastar Medical Holding Corp C/Wts 28/10/2027 涨幅较大，Eterna Therapeutics Inc.、Azitra Inc、Silo Pharma, Inc.较为活跃，换手率分别为148.73%、59.20%、47.08%，振幅较大的相关个股有Eterna Therapeutics Inc.、Fate Therapeutics, Inc.、Lexaria Bioscience Corp.，振幅分别为75.47%、20.93%、20.87%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114223644a221b9ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114223644a221b9ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RA","BK4139","ANAB"],"gpt_icon":0},{"id":"2503891605","title":"Igm Biosciences, Inc.盤中異動 早盤股價大跌5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503891605","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503891605?lang=zh_tw&edition=fundamental","pubTime":"2025-01-13 23:23","pubTimestamp":1736781808,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日23时23分，Igm Biosciences, Inc.股票出现波动，股价大幅下挫5.18%。Igm Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为1.43%。其相关个股中，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为8609.79%、4066.12%、414.83%，振幅较大的相关个股有Phio Pharmaceuticals Corp.、Kairos Pharma, Ltd.、Salarius Pharmaceuticals, Inc.，振幅分别为318.93%、124.54%、106.07%。Igm Biosciences, Inc.公司简介：IGM Biosciences Inc是一家从事 IgM 抗体疗法开发的生物技术公司，用于治疗癌症、传染病以及自身免疫和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113232328aba93e45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113232328aba93e45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLE","BK4505","IGMS","RA","BK4077","BK4139"],"gpt_icon":0}],"pageSize":16,"totalPage":9,"pageCount":3,"totalSize":141}]}}